Coeptis Common Stock vs Total Liab Analysis

COEPW Stock

USD 0.02 0 19.50%

Coeptis Therapeutics financial indicator trend analysis is way more than just evaluating Coeptis Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Coeptis Therapeutics is a good investment. Please check the relationship between Coeptis Therapeutics Common Stock and its Total Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Coeptis Stock please use our How to Invest in Coeptis Therapeutics guide.

Common Stock vs Total Liab

Common Stock vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Coeptis Therapeutics Common Stock account and Total Liab. At this time, the significance of the direction appears to have pay attention.

The correlation between Coeptis Therapeutics' Common Stock and Total Liab is -0.84. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Total Liab in the same time period over historical financial statements of Coeptis Therapeutics Holdings, assuming nothing else is changed. The correlation between historical values of Coeptis Therapeutics' Common Stock and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Coeptis Therapeutics Holdings are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Common Stock i.e., Coeptis Therapeutics' Common Stock and Total Liab go up and down completely randomly.

Correlation Coefficient

-0.84

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Common Stock

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Coeptis Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Coeptis Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Coeptis Stock please use our How to Invest in Coeptis Therapeutics guide.Issuance Of Capital Stock is likely to climb to about 5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 24.3 M in 2024.

	2021	2022	2023	2024 (projected)
Other Operating Expenses	14.1M	34.2M	39.3M	41.3M
Depreciation And Amortization	447.4K	1.0M	901.2K	719.4K

Other Operating Expenses Depreciation And Amortization

Coeptis Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Non Currrent Assets Other	Other Current Liab	Property Plant And Equipment Net	Other Assets	Long Term Debt	Net Receivables	Non Current Liabilities Total	Capital Lease Obligations
Total Assets		0.72	0.46	0.87	-0.59	-0.96	-0.07	0.99	0.92	0.99	0.42	0.97	0.66	0.99	0.76	-0.71	-0.75	0.88	0.24	-0.98	-0.3	-0.71	0.31	-0.93	0.96	0.18
Short Long Term Debt Total	0.72		0.79	0.35	0.11	-0.66	0.37	0.64	0.82	0.64	0.27	0.64	0.91	0.64	0.97	-0.29	-0.76	0.86	-0.2	-0.79	-0.71	-0.29	0.75	-0.87	0.84	-0.31
Total Current Liabilities	0.46	0.79		-0.04	0.19	-0.53	0.83	0.45	0.46	0.45	0.13	0.53	0.96	0.45	0.88	-0.26	-0.76	0.83	-0.72	-0.47	-0.3	-0.26	0.31	-0.49	0.48	-0.06
Total Stockholder Equity	0.87	0.35	-0.04		-0.8	-0.79	-0.54	0.87	0.77	0.87	0.41	0.8	0.19	0.87	0.35	-0.67	-0.42	0.52	0.67	-0.84	-0.13	-0.67	0.13	-0.76	0.8	0.27
Net Debt	-0.59	0.11	0.19	-0.8		0.66	0.44	-0.68	-0.4	-0.68	-0.35	-0.67	0.05	-0.68	0.0	0.59	0.24	-0.29	-0.5	0.5	-0.46	0.59	0.48	0.31	-0.4	-0.66
Retained Earnings	-0.96	-0.66	-0.53	-0.79	0.66		-0.07	-0.98	-0.87	-0.98	-0.43	-1.0	-0.69	-0.98	-0.75	0.65	0.8	-0.89	-0.1	0.94	0.13	0.65	-0.13	0.84	-0.89	-0.29
Accounts Payable	-0.07	0.37	0.83	-0.54	0.44	-0.07		-0.05	-0.08	-0.05	-0.16	0.07	0.66	-0.05	0.48	0.06	-0.46	0.41	-0.97	0.07	0.01	0.06	-0.01	0.07	-0.07	-0.03
Cash	0.99	0.64	0.45	0.87	-0.68	-0.98	-0.05		0.88	1.0	0.42	0.99	0.63	1.0	0.71	-0.75	-0.75	0.87	0.22	-0.95	-0.17	-0.75	0.17	-0.87	0.91	0.29
Non Current Assets Total	0.92	0.82	0.46	0.77	-0.4	-0.87	-0.08	0.88		0.88	0.49	0.85	0.68	0.87	0.82	-0.42	-0.71	0.81	0.26	-0.98	-0.46	-0.42	0.53	-0.96	0.99	0.03
Cash And Short Term Investments	0.99	0.64	0.45	0.87	-0.68	-0.98	-0.05	1.0	0.88		0.42	0.99	0.63	1.0	0.71	-0.75	-0.75	0.87	0.22	-0.95	-0.17	-0.75	0.17	-0.87	0.91	0.29
Common Stock Shares Outstanding	0.42	0.27	0.13	0.41	-0.35	-0.43	-0.16	0.42	0.49	0.42		0.41	0.25	0.42	0.33	-0.14	0.07	0.34	0.13	-0.44	0.06	-0.14	0.03	-0.36	0.42	0.3
Other Stockholder Equity	0.97	0.64	0.53	0.8	-0.67	-1.0	0.07	0.99	0.85	0.99	0.41		0.68	0.99	0.74	-0.72	-0.79	0.9	0.1	-0.93	-0.11	-0.72	0.1	-0.83	0.88	0.32
Total Liab	0.66	0.91	0.96	0.19	0.05	-0.69	0.66	0.63	0.68	0.63	0.25	0.68		0.63	0.97	-0.32	-0.84	0.93	-0.51	-0.68	-0.4	-0.32	0.43	-0.7	0.7	-0.06
Total Current Assets	0.99	0.64	0.45	0.87	-0.68	-0.98	-0.05	1.0	0.87	1.0	0.42	0.99	0.63		0.71	-0.76	-0.74	0.87	0.21	-0.95	-0.16	-0.76	0.16	-0.86	0.91	0.3
Short Term Debt	0.76	0.97	0.88	0.35	0.0	-0.75	0.48	0.71	0.82	0.71	0.33	0.74	0.97	0.71		-0.35	-0.83	0.94	-0.32	-0.8	-0.53	-0.35	0.57	-0.83	0.83	-0.12
Intangible Assets	-0.71	-0.29	-0.26	-0.67	0.59	0.65	0.06	-0.75	-0.42	-0.75	-0.14	-0.72	-0.32	-0.76	-0.35		0.48	-0.6	-0.16	0.57	-0.07	1.0	0.12	0.51	-0.53	-0.42
Common Stock	-0.75	-0.76	-0.76	-0.42	0.24	0.8	-0.46	-0.75	-0.71	-0.75	0.07	-0.79	-0.84	-0.74	-0.83	0.48		-0.88	0.25	0.75	0.29	0.48	-0.29	0.72	-0.74	-0.07
Current Deferred Revenue	0.88	0.86	0.83	0.52	-0.29	-0.89	0.41	0.87	0.81	0.87	0.34	0.9	0.93	0.87	0.94	-0.6	-0.88		-0.25	-0.86	-0.32	-0.6	0.33	-0.83	0.85	0.1
Non Currrent Assets Other	0.24	-0.2	-0.72	0.67	-0.5	-0.1	-0.97	0.22	0.26	0.22	0.13	0.1	-0.51	0.21	-0.32	-0.16	0.25	-0.25		-0.25	-0.11	-0.16	0.11	-0.25	0.25	0.01
Other Current Liab	-0.98	-0.79	-0.47	-0.84	0.5	0.94	0.07	-0.95	-0.98	-0.95	-0.44	-0.93	-0.68	-0.95	-0.8	0.57	0.75	-0.86	-0.25		0.41	0.57	-0.43	0.97	-0.99	-0.07
Property Plant And Equipment Net	-0.3	-0.71	-0.3	-0.13	-0.46	0.13	0.01	-0.17	-0.46	-0.17	0.06	-0.11	-0.4	-0.16	-0.53	-0.07	0.29	-0.32	-0.11	0.41		-0.07	-0.97	0.61	-0.51	0.83
Other Assets	-0.71	-0.29	-0.26	-0.67	0.59	0.65	0.06	-0.75	-0.42	-0.75	-0.14	-0.72	-0.32	-0.76	-0.35	1.0	0.48	-0.6	-0.16	0.57	-0.07		0.12	0.51	-0.53	-0.42
Long Term Debt	0.31	0.75	0.31	0.13	0.48	-0.13	-0.01	0.17	0.53	0.17	0.03	0.1	0.43	0.16	0.57	0.12	-0.29	0.33	0.11	-0.43	-0.97	0.12		-0.63	0.54	-0.73
Net Receivables	-0.93	-0.87	-0.49	-0.76	0.31	0.84	0.07	-0.87	-0.96	-0.87	-0.36	-0.83	-0.7	-0.86	-0.83	0.51	0.72	-0.83	-0.25	0.97	0.61	0.51	-0.63		-0.99	0.14
Non Current Liabilities Total	0.96	0.84	0.48	0.8	-0.4	-0.89	-0.07	0.91	0.99	0.91	0.42	0.88	0.7	0.91	0.83	-0.53	-0.74	0.85	0.25	-0.99	-0.51	-0.53	0.54	-0.99		-0.01
Capital Lease Obligations	0.18	-0.31	-0.06	0.27	-0.66	-0.29	-0.03	0.29	0.03	0.29	0.3	0.32	-0.06	0.3	-0.12	-0.42	-0.07	0.1	0.01	-0.07	0.83	-0.42	-0.73	0.14	-0.01

Click cells to compare fundamentals

Coeptis Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Coeptis Stock Analysis

When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Coeptis Common Stock vs Total Liab Analysis

Common Stock vs Total Liab

Common Stock vs Total Liab Correlation Analysis

Correlation Coefficient

Common Stock

Total Liab

Coeptis Therapeutics fundamental ratios Correlations

Coeptis Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Coeptis Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Other Assets	+ 1.0	Intangible Assets
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets

Other Stockholder Equity	- 1.0	Retained Earnings
Non Current Liabilities Total	- 0.99	Net Receivables
Non Current Liabilities Total	- 0.99	Other Current Liab
Other Current Liab	- 0.98	Non Current Assets Total
Total Current Assets	- 0.98	Retained Earnings
Cash And Short Term Investments	- 0.98	Retained Earnings